Research Keyword: Drug resistance mechanisms

John Perfect Shares Insights on Infectious Diseases, Antifungal Therapy, and Drug Resistance

mycolabadmin

Dr. John Perfect, a leading infectious disease expert, discusses his 48-year career studying fungal infections, particularly cryptococcal meningitis. He reflects on the dramatic transformation of HIV/AIDS from a fatal disease to a manageable chronic condition and emphasizes that antifungal resistance is less concerning than the underlying diseases that complicate treatment. Perfect advocates for developing more potent antifungal drugs that work faster, and discusses promising approaches like molecular diagnostics and immune-based therapies to improve patient outcomes.

Read More »

Appearance of Environment-Linked Azole Resistance in the Aspergillus fumigatus Complex in New Zealand

mycolabadmin

Researchers in New Zealand have discovered that a dangerous fungus called Aspergillus fumigatus is developing resistance to commonly used antifungal medications. Unlike previous cases where the resistance came from medical treatment, this new resistance appears to come from environmental exposure, possibly through garden fungicides that people can buy at garden centers. The study found that people, especially lung transplant patients, may be acquiring these resistant fungal strains from their surroundings rather than from hospitals, highlighting the need for better monitoring of agricultural fungicide use.

Read More »

The in vitro Activity of Echinocandins Against Clinical Trichophyton rubrum Isolates and Review of the Susceptibility of T. rubrum to Echinocandins Worldwide

mycolabadmin

Researchers tested how well three antifungal drugs (micafungin, anidulafungin, and caspofungin) work against a common fungus that causes skin infections. They found that two of these drugs were more effective than the third, suggesting they could be helpful alternatives when standard treatments fail due to drug-resistant fungal strains. The study also reviewed similar research worldwide and found consistent results across different testing methods.

Read More »

Caspofungin therapy in prosthetic valve endocarditis and candidemia due to itraconazole-resistant Candida glabrata (Nakaseomyces glabratus): A case report

mycolabadmin

A 13-year-old boy developed a serious fungal infection of his heart valve after receiving an artificial valve replacement. The initial antibiotic (itraconazole) did not work because the fungus became resistant, likely by forming a protective biofilm. After identifying the resistant fungus through specialized testing, doctors switched to a different medication called caspofungin. The patient fully recovered with this new treatment and remained healthy during follow-up, showing that combination of precise identification and targeted treatment can overcome antibiotic resistance.

Read More »

Unlocking the potential of experimental evolution to study drug resistance in pathogenic fungi

mycolabadmin

Fungal infections are becoming harder to treat as fungi develop resistance to antifungal drugs. This review explains how scientists can use experimental evolution—growing fungi in controlled laboratory conditions while exposing them to drugs—to understand how and why resistance develops. By studying these evolutionary processes and using mathematical models to predict outcomes, researchers can develop better treatment strategies, including combination therapies and drug cycling approaches to prevent resistance from emerging.

Read More »
Scroll to Top